Literature DB >> 6285711

Renal function after acyclovir intravenous injection.

D Brigden, A E Rosling, N C Woods.   

Abstract

Plasma urea or creatinine was noted to be raised in 58 of 354 patients treated with intravenous acyclovir. This occurred after intravenous bolus injection of high dosages of acyclovir but the risk was considerably reduced by slow intravenous infusion of the same dosage over one hour, with adequate hydration of the patient and adjustment of dosage in patients with preexisting impaired renal function. Animal studies indicate that the impairment of renal function associated with high bolus injections of acyclovir is due to crystal formation in the renal tubules and/or the collecting ducts, and that the crystals are removed after cessation of treatment. The special problems involved in the treatment of patients with herpes encephalitis necessitating limited fluid intake and the possible interaction with other nephrotoxic drugs are discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6285711     DOI: 10.1016/0002-9343(82)90087-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  29 in total

1.  Acyclovir-induced coma in a young patient without preexisting renal impairment.

Authors:  Samuel Delerme; Bernard De Jonghe; Olivier Proost; Herve Outin
Journal:  Intensive Care Med       Date:  2002-03-20       Impact factor: 17.440

2.  Acyclovir-induced renal failure: course and risk factors.

Authors:  M G Bianchetti; C Roduit; O H Oetliker
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

Review 3.  Clinically significant drug interactions with cyclosporin. An update.

Authors:  C Campana; M B Regazzi; I Buggia; M Molinaro
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

4.  Aciclovir-induced acute kidney injury in patients with 'suspected viral encephalitis' encountered on a liaison neurology service.

Authors:  Petya Bogdanova-Mihaylova; David Burke; John P O'Dwyer; David Bradley; Jennifer A Williams; Simon J Cronin; Shane Smyth; Raymond P Murphy; Sinead M Murphy; Catherine Wall; Dominick J H McCabe
Journal:  Ir J Med Sci       Date:  2018-01-06       Impact factor: 1.568

5.  Acute kidney injury due to acyclovir.

Authors:  Cigdem Yildiz; Yasemin Ozsurekci; Safak Gucer; Ali Bulent Cengiz; Rezan Topaloglu
Journal:  CEN Case Rep       Date:  2012-10-01

6.  Genistein Has Antiviral Activity against Herpes B Virus and Acts Synergistically with Antiviral Treatments to Reduce Effective Dose.

Authors:  Julia C LeCher; Nga Diep; Peter W Krug; Julia K Hilliard
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

7.  Gross-structural defects in rats after acyclovir application on day 10 of gestation.

Authors:  I Chahoud; R Stahlmann; G Bochert; I Dillmann; D Neubert
Journal:  Arch Toxicol       Date:  1988-08       Impact factor: 5.153

8.  Acyclovir therapy for chickenpox in children with hematological malignancies.

Authors:  J Bogusławska-Jaworska; E Kościelniak; B Rodziewicz
Journal:  Eur J Pediatr       Date:  1984-06       Impact factor: 3.183

9.  Nephrotoxicity of acyclovir and cis-diamminedichloroplatinum(II)--effect of co-administration in rats.

Authors:  J Hannemann; W Wunderle; K Baumann
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

10.  Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers.

Authors:  B G Petty; R J Whitley; S Liao; H C Krasny; L E Rocco; L G Davis; P S Lietman
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.